An official website of the United States government Here's how you know

The .gov means it's official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Drugs@FDA: FDA-Approved Drugs

Home | Previous Page

Biologic License Application (BLA): 125249
Company: KINIKSA PHARMACEUTICALS (UK), LTD.

Products on BLA 125249

Drug Name	Active Ingredients	Strength	Dosage Form/Route	Marketing Status	TE Code	RLD	RS
ARCALYST	RILONACEPT	220MG	VIAL; SINGLE-USE	Prescription	None	No	No

Approval Date(s) and History, Letters, Labels, Reviews for BLA 125249

Original Approvals or Tentative Approvals

Action Date	Submission	Action Type	Submission Classification	Review Priority; Orphan Status	Letters, Reviews, Labels, Patient Package Insert	Notes	Url
02/27/2008	ORIG-1	Approval		N/A; Orphan	Label (PDF) Letter (PDF) Review		https://www.accessdata.fda.gov/drugsatfda_docs/label/2008/125249lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2008/125249s000ltr.pdf https://www.accessdata.fda.gov/drugsatfda_docs/nda/2008/125249s000TOC.cfm

Supplements

Action Date	Submission	Supplement Categories or Approval Type	Letters, Reviews, Labels, Patient Package Insert	Note	Url
03/18/2021	SUPPL-49	Supplement	Label (PDF) Letter (PDF)		https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/125249s049lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2021/125249Orig1s049ltr.pdf
12/18/2020	SUPPL-47	Supplement	Label (PDF) Letter (PDF)		https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/125249s047lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2020/125249Orig1s047ltr.pdf
02/12/2020	SUPPL-45	Supplement	Label (PDF) Letter (PDF)		https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/125249s045lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2020/125249Orig1s045ltr.pdf
09/30/2010	SUPPL-18	Supplement		Label is not available on this site.

Labels for BLA 125249

Action Date	Submission	Supplement Categories or Approval Type	Letters, Reviews, Labels, Patient Package Insert	Note	Url
03/18/2021	SUPPL-49	Efficacy-New Indication	Label (PDF)		https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/125249s049lbl.pdf
12/18/2020	SUPPL-47	Efficacy-Labeling Change With Clinical Data	Label (PDF)		https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/125249s047lbl.pdf
02/12/2020	SUPPL-45	Labeling-Package Insert	Label (PDF)		https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/125249s045lbl.pdf
02/27/2008	ORIG-1	Approval	Label (PDF)		https://www.accessdata.fda.gov/drugsatfda_docs/label/2008/125249lbl.pdf

Top